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Design of study: Although diabetic retinopathy (DR) has long been considered a microcirculatory 
disease, recent evidence shows that retinal neurodegeneration may occur early in its 
pathogenesis. New treatments targeting both vascular and neuronal damage are therefore needed. 
Endothelial cells, pericytes and Mϋller cells are three important components of the inner blood-
retinal barrier (iBRB), playing a key-role during the development of DR. Mϋller cells may act as a 
link between microvascular damage and neurodegeneration. High glucose-induced metabolic 
damage in microvascular cells in vitro and progression of retinopathy in diabetic animals is 
prevented by thiamine. Diabetic subjects often show decreased levels of thiamine. 
Purpose: This study was aimed at verifying if thiamine protects the iBRB from stress and 
apoptosis induced by diabetic-like conditions, and examine the molecular mechanisms involved in 
preventing damage. 
Methods: Human Microvascular Endothelial cells (HMEC), retinal pericytes (HRP), and Müller 
cells (MIO-M1) were exposed to hyperglycaemic-like conditions (intermittent high glucose, intHG, 
and/or hypoxia), with/without thiamine over-supplementation. The expression of the adhesion 
molecules CD29, αVβ3 and ICAM-1 were investigated by FACS, metalloproteases MMP-2, MMP-
9, and their inhibitor TIMP-1 by Western blotting, and the synthesis and secretion of angiogenic 
factors (VEGF, Ang1, Ang2, HIF-1α) by ELISA and Western blotting. 
Results: MMP2 and MMP9 expression was increased by intHG and normalized by thiamine in all 
cell types, while TIMP-1 increased in HRP only. Diabetic like-conditions enhanced the expression 
of Ang2, VEGF and HIF-1α in HMEC, which was again counteracted by thiamine. As regards 
adhesion molecules, CD29 was increased in HRP by intHG and ICAM-1 in HMEC by 
intHG+hypoxia; again thiamine was able to neutralize these effects.  
Conclusions: Diabetic-like conditions impair the expression of angiogenic molecules in cells of the 
iBRB. Endothelial cells and pericytes seem to be the primary targets. Thiamine supplementation is 
able to counteract the damage induced by high glucose and hypoxia. Therefore, thiamine could be 
further investigated as a putative therapeutic approach for DR. 
 
